2. Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
6 Months Ended | 12 Months Ended | |
---|---|---|---|
Jun. 25, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||
Reverse stock split | 1-for-12 reverse stock split | ||
Letter of credit | $ 0 | $ 100,000 | |
Letter of credit purpose | Lexington Lease | ||
Impairment of long-lived assets | 0 | $ 0 | |
Accrued expenses and other current liabilities | 484,029 | 665,641 | |
Prepaid expenses and other | $ 722,079 | $ 555,856 | |
Antidilutive shares | 516,000 | 65,000 | |
JSOP [Member] | |||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||
Awards outstanding | 27,000 | 27,000 | |
Accrued Program Expense [Member] | |||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||
Accrued expenses and other current liabilities | $ 100,000 | $ 200,000 | |
Deposits held with clinical trial vendors [Member] | |||
Basis Of Presentation And Significant Accounting Policies [Line Items] | |||
Prepaid expenses and other | $ 700,000 | $ 700,000 |
X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of a specific compensating balance arrangement that is maintained under an agreement for a bank loan or future credit availability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A description of the entity's reasons and intentions for maintaining a specific compensating balance arrangement that is maintained under an agreement for a bank loan or future credit availability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Basis Of Presentation And Significant Accounting Policies [Line Items] No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|